Developing Personalised Relative Physical Activity Thresholds in COPD. (IMPACT)

May 18, 2026 updated by: University of Leicester

Developing Personalised, Relative Intensity Physical Activity Thresholds for Accelerometer-Derived Measures of Physical Activity in COPD (IMPACT)

The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity.

The main questions this study aims to answer are:

  • Phase 1: What does physical activity (intensity) mean to people with COPD?
  • Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD?

Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires.

Phase 2:

Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class.

Sub-study:

Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.

Study Overview

Status

Completed

Detailed Description

Physical activity (PA) helps prevent and manage non-communicable diseases such as chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation (PR) has been shown to benefit people living with COPD by reducing breathlessness, increasing muscle strength, and improving the management of exacerbations. However, the improvement in PA in individuals with COPD remains inconsistent following PR. Despite the personalised nature of PA prescription during PR, the evaluation of free-living PA data has been limited to a 'one size fits all' approach using absolute intensity categories. Reduced exercise tolerance can result in PA being perceived at a high intensity relative to a person's exercise capacity, despite the absolute intensity being low. Exploring both the relative and absolute intensity of PA could offer additional insights and clinical relevance for the evaluation of physical activity in COPD populations.

The aim of this research is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity PA in a user-friendly format for PR teams and service users.

Phase 1 objective: To explore what PA means to people with COPD in the context of relative intensity and pulmonary rehabilitation.

Phase 2 objective: To examine the differences between time spent in physical activity intensity expressed in absolute and relative terms for people with COPD.

Phase 1: Semi-structured interviews will take place where participants will discuss their COPD and their perceptions of physical activity and relative intensity. The interviews will be in person (Biomedical research centre, Leicester) or over the phone/video call. The participants will complete several questionnaires about respiratory symptoms. Before taking part in the interviews, participants will also be asked to take pictures, using a camera provided, of when they are doing physical activity. This will be for a 7 day period before the interview.

Phase 2: Participants will take part in exercise testing and complete questionnaires pre and post pulmonary rehabilitation while wearing activity and gait monitors. Participants will also be asked to wear the activity monitors for 8-days after the pre-testing sessions and 8-days after their last pulmonary rehabilitation class. Following their last pulmonary rehabilitation class, 20 participants will be asked to take photographs during the period they are wearing accelerometers and motion sensors. When the participants return the devices, they will take part in an interview to discuss the images they have taken while taking part in physical activity.

Study Type

Observational

Enrollment (Actual)

54

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Leicester, Leicestershire, United Kingdom, LE67 2DU
        • NIHR Leicester Biomedical Research Centre - Respiratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Phase 1:

Patients from the COPD nursing ward, previous research studies and pulmonary rehabilitation programme.

Phase 2:

Patients from the pulmonary rehabilitation programme.

Description

Phase 1:

Inclusion Criteria:

  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustí et al., 2023).
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English.

Exclusion Criteria:

  • Unable to provide valid informed consent.
  • Severe psychiatric disorders
  • Aged less than 40 years
  • Unable to understand written or spoken English.

Phase 2:

Inclusion Criteria:

  • Willing and able to provide informed consent for participation in the research.
  • The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria.
  • The patient is referred for PR at the UHL.
  • Male or female, aged 40+ years
  • Able to communicate in written and spoken English

Exclusion Criteria:

  • Unable to provide valid informed consent.
  • Lack of motivation to participate in PR programme.
  • Any-contra-indications absolute or relative to exercise training.
  • Has had a cardiac event within last 6 weeks
  • Severe psychiatric disorders
  • Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend).
  • Aged less than 40 years
  • Unable to understand written or spoken English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Phase 1 Cohort

These participants will be recruited from:

  • Previous research studies
  • COPD nursing ward
  • Pulmonary rehabilitation
Phase 2 Cohort
These participants will be recruited from the pulmonary rehabilitation service.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase 1 - Semi-structured Interviews
Time Frame: 30-45 minutes
Semi-structured interview with individuals with COPD
30-45 minutes
Phase 2 - Differences between time spent in PA intensity expressed in absolute and relative intensity.
Time Frame: 8 days
Differences between time spent in PA intensity expressed in absolute and relative using activity monitors (wrist and waist) for eight days before and after the PR programme.
8 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase 1 - Medical Research Council (MRC) Dyspnoea Scale
Time Frame: 2 minutes
Medical Research Council (MRC) Dyspnoea Scale Minimum value: 1 Maximum value: 5 The higher the score, the worse the outcome (breathlessness).
2 minutes
Phase 1 - COPD Assessment Test (CAT)
Time Frame: 5 minutes
COPD Assessment Test (CAT)
5 minutes
Phase 1 - Chronic Respiratory Questionnaire (CRQ-SR)
Time Frame: 5 minutes
Chronic Respiratory Questionnaire (CRQ-SR)
5 minutes
Phase 1 - Photovoice and photo-elicitation
Time Frame: 7 days
Photovoice is a qualitative research method that focuses on participants identifying and addressing important topics that matter to them through photography. This will gain greater insight from the participants about their experiences of participating in PA. Participant-generated images will be used to inform the photo-elicitation aspect of the interview to enable participants to capture in real time, more graphically illustrate their experiences and perceptions of different types of PA.
7 days
Phase 2 - Medical Research Council (MRC) Dyspnoea Scale
Time Frame: 2 minutes
Medical Research Council (MRC) Dyspnoea Scale
2 minutes
Phase 2 - COPD Assessment Test (CAT)
Time Frame: 5 minutes
COPD Assessment Test (CAT)
5 minutes
Phase 2 - Chronic Respiratory Questionnaire (CRQ-SR)
Time Frame: 5 minutes
Chronic Respiratory Questionnaire (CRQ-SR)
5 minutes
Phase 2 - Gait Analysis
Time Frame: 45 minutes
Gait Analysis - Speed, Variability, Asymmetry
45 minutes
Phase 2 - Exercise Capacity (ISWT)
Time Frame: 30-45 minutes
Incremental Shuttle Walk Test
30-45 minutes
Phase 2 - Exercise Capacity (ESWT)
Time Frame: 15-30 minutes
Endurance Shuttle Walk Test
15-30 minutes
Phase 2 - Photovoice and photo-elicitation
Time Frame: 8 days
Photovoice is a qualitative research method that focuses on participants identifying and addressing important topics that matter to them through photography. This will gain greater insight from the participants about their experiences of participating in PA. Participant-generated images will be used to inform the photo-elicitation aspect of the interview to enable participants to capture in real time, more graphically illustrate their experiences and perceptions of different types of PA.
8 days
Phase 2 - Clinical PROactive Physical Activity instrument in COPD (C-PPAC)
Time Frame: 5 minutes
Clinical PROactive Physical Activity instrument in COPD (C-PPAC)
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: University of Leicester University of Leicester, University of Leicester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2023

Primary Completion (Actual)

October 28, 2025

Study Completion (Actual)

March 31, 2026

Study Registration Dates

First Submitted

March 4, 2024

First Submitted That Met QC Criteria

March 18, 2024

First Posted (Actual)

March 26, 2024

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data will only be available in publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Subscribe